Abivax S.A. (ABVX)
Healthcare
Biotechnology
124.80 $
-0.1%
vs. previous close
Closing price · As of: 3. Aug 2026
Abivax S.A. (ABVX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -156 million EUR. Tick rows to compare them in a chart.
All figures in millions of EUR.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.3 | -15 | -16 | -8.4 | -15 | -27 | -30 | -46 | -54 | -100 | -154 | -156 | |
| 0.0 | 0.1 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.5 | 0.7 | 1.1 | 1.0 | |
| – | – | – | – | – | – | – | 0.8 | -1.2 | 8.2 | 20 | 35 | |
| – | – | – | – | – | -3.9 | -2.0 | -2.2 | 8.3 | – | – | – | |
| 1.7 | 3.4 | 2.5 | 5.5 | 4.7 | 7.0 | 9.7 | -0.7 | -2.0 | 21 | 1.4 | 3.5 | |
| 0.0 | 1.0 | 0.7 | 1.0 | 0.8 | 0.9 | 0.9 | 1.6 | 0.3 | 0.3 | 0.6 | 0.1 | |
| 0.0 | -1.0 | -0.1 | -0.1 | -0.3 | -0.4 | -0.6 | -1.5 | -12 | -10 | 16 | -13 | |
| – | – | – | – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| – | – | – | – | – | 11 | 24 | 19 | -9.8 | 15 | 37 | -60 | |
| 5.9 | 52 | -0.4 | 2.6 | 11 | 25 | 50 | 79 | 32 | 341 | 28 | 532 | |
| 2.9 | 36 | -16 | -6.0 | -4.0 | -3.2 | 20 | 31 | -34 | 225 | -108 | 389 | |
| -3.3 | -16 | -16 | -9.4 | -15 | -28 | -31 | -47 | -54 | -100 | -155 | -156 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.